{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:55Z","timestamp":1790375995941,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":3219,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Health and \u2018Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en C\u00e1ncer\u2019","award":["FIS-IP07\/0409"],"award-info":[{"award-number":["FIS-IP07\/0409"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["RD06\/0020\/0051"],"award-info":[{"award-number":["RD06\/0020\/0051"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1093\/annonc\/mdq359","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T01:22:28Z","timestamp":1279156948000},"page":"397-404","source":"Crossref","is-referenced-by-count":97,"title":["Comparison of four prognostic scores in peripheral T-cell lymphoma"],"prefix":"10.1016","volume":"22","author":[{"given":"G.","family":"Guti\u00e9rrez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cardesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Villamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ghita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mart\u00ednez-Trillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Colomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Setoain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq359_bb0010","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1093\/annonc\/mdq359_bb0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification","volume":"8","author":"Ascani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years","volume":"16","author":"Au","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0030","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification","volume":"9","author":"Lopez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOH.0b013e32832b89a9","article-title":"The spectrum of peripheral T-cell lymphomas","volume":"16","author":"O'Leary","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1093\/annonc\/mdq359_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","article-title":"Molecular classification of T-cell lymphomas","volume":"72","author":"de Leval","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdq359_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2008.10.011","article-title":"Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets","volume":"71","author":"Rodriguez","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdq359_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/hon.897","article-title":"Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?","volume":"27","author":"Fornari","year":"2009","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0060","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2006-07-038000","article-title":"BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?","volume":"109","author":"Dunleavy","year":"2007","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq359_bb0070","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq359_bb0075","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/jcp.2008.055335","article-title":"Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies","volume":"61","author":"Agostinelli","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1093\/annonc\/mdq359_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hon.836","article-title":"Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review","volume":"26","author":"Rodriguez-Abreu","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.blre.2007.03.001","article-title":"Peripheral T-cell lymphomas","volume":"21","author":"Savage","year":"2007","journal-title":"Blood Rev"},{"key":"10.1093\/annonc\/mdq359_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0095","first-page":"987","article-title":"The International Non-Hodgkin's Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq359_bb0100","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq359_bb0105","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq359_bb0110","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","article-title":"Clinical features and prognostic factors of patients with \u201cperipheral T cell lymphoma, unspecified\u201d","volume":"88","author":"Lee","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdq359_bb0120","doi-asserted-by":"crossref","first-page":"811a","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International Peripheral T-cell Lymphoma (PTCL) Clinical and Pathology Review Project: poor outcome by prognostic indices and lack of efficacy with anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq359_bb0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdq359_bb0135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2307\/2529177","article-title":"Conservatism of the approximation \u2211(O-E)2\/E in the log-rank test for survival data or tumour incidence data","volume":"29","author":"Peto","year":"1973","journal-title":"Biometrics"},{"key":"10.1093\/annonc\/mdq359_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Assoc"},{"key":"10.1093\/annonc\/mdq359_bb0145","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1200\/JCO.2005.05.015","article-title":"State-of-the-art therapeutics: diffuse large B-cell lymphoma","volume":"23","author":"Coiffier","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0150","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0160","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood-2009-12-257014","article-title":"Molecular signatures in T-cell lymphoma","volume":"115","author":"Gisselbrecht","year":"2010","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq359_bb0165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/annonc\/mdn022","article-title":"Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma","volume":"19","author":"Mercadal","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0170","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/annonc\/mdh471","article-title":"All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)","volume":"15","author":"Mounier","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/10428190310001597955","article-title":"Stem cell transplantation for peripheral T-cell lymphomas","volume":"45","author":"Jantunen","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdq359_bb0180","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdq359_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.bmt.1705712","article-title":"Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen","volume":"40","author":"Smith","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdq359_bb0190","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/10428190701435275","article-title":"Hematopoietic stem cell transplantation in peripheral T-cell lymphomas","volume":"48","author":"Paolo","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdq359_bb0195","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq359_bb0200","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdq359_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2257.2000.00307.x","article-title":"Angiocentric nasal T\/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients","volume":"22","author":"Aviles","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1093\/annonc\/mdq359_bb0210","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","article-title":"Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy","volume":"41","author":"Lee","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdq359_bb0215","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdn696","article-title":"The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia\/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project","volume":"20","author":"Suzumiya","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419386612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419386612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/22\/2\/397\/406543\/mdq359.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T22:36:21Z","timestamp":1740263781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419386612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0923753419386612"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq359","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}